Patents by Inventor Yi-He Ling

Yi-He Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
    Publication number: 20130225690
    Abstract: The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Application
    Filed: September 20, 2012
    Publication date: August 29, 2013
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman Perez-Soler, Yi-He Ling
  • Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
    Patent number: 8283382
    Abstract: The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Grant
    Filed: May 26, 2010
    Date of Patent: October 9, 2012
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman Perez-Soler, Yi-He Ling
  • VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
    Publication number: 20100324148
    Abstract: The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 23, 2010
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman Perez-Soler, Yi-He Ling
  • Antitumoral Treatments
    Publication number: 20100226919
    Abstract: The present invention relates to combinations of PM02734 with EGFR tyrosine kinase inhibitors, and the use of these combinations in the treatment of cancer.
    Type: Application
    Filed: October 17, 2008
    Publication date: September 9, 2010
    Applicants: Pharma Mar, S.A., ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
    Inventors: Román Pérez-Soler, Yi-He Ling, José Maria Jimeno Donaque, Yi-Yu Zou
  • Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
    Patent number: 7745494
    Abstract: The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: June 29, 2010
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman Perez-Soler, Yi-He Ling
  • VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
    Publication number: 20090239952
    Abstract: The invention provides methods and compositions tor treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (BGKR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Application
    Filed: May 14, 2009
    Publication date: September 24, 2009
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman PEREZ-SOLER, Yi-He LING
  • Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy
    Publication number: 20090209652
    Abstract: The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
    Type: Application
    Filed: April 12, 2006
    Publication date: August 20, 2009
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Roman Perez-Soler, Yi-He Ling
  • Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
    Patent number: 6680300
    Abstract: The present invention discloses new and novel substituted anthracyclines having a three ring system or other DNA binding moieties. These congeners show high activity in vitro against several tumor cell lines. The invention also describes anthracycline-based DNA alkylators.
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: January 20, 2004
    Assignee: Board of Regents, The University of Texas System
    Inventors: Waldemar Priebe, Teresa Przewloka, Izabela Fokt, Yi-He Ling, Roman Perez-Soler
  • Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
    Publication number: 20030023052
    Abstract: The present invention discloses new and novel substituted anthracyclines having a three ring system or other DNA binding moieties. These congeners show high activity in vitro against several tumor cell lines. The invention also describes anthracycline-based DNA alkylators.
    Type: Application
    Filed: August 19, 2002
    Publication date: January 30, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Waldemar Priebe, Teresa Przewloka, Izabela Fokt, Yi-He Ling, Roman Perez-Soler
  • Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents
    Patent number: 6437105
    Abstract: The present invention discloses new and novel substituted anthracyclines having a three ring system or other DNA binding moieties. These congeners show high activity in vitro against several tumor cell lines. The invention also describes anthracycline-based DNA alkylators.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: August 20, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: Waldemar Priebe, Teresa Przewloka, Izabela Fokt, Yi-He Ling, Roman Perez-Soler